In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Integrating new AI screening tools for BRCA and HRD breast-cancer mutations into routine care could lead to earlier detection, more precise treatment, and lives saved. If they are aware of the threat, ...

A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

Up to 5% of Americans may carry genetic variants associated with cancer risk, according to a cross-sectional analysis.The ...

The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host and producer of TED Health, and founder of End Well, a nonprofit ...

Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...